Reviva Pharmaceuticals
RVPH
RVPH
13 hedge funds and large institutions have $2.05M invested in Reviva Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Holders
13
Holding in Top 10
–
Calls
$330K
Puts
–
Top Buyers
| 1 | +$11.3K | |
| 2 | +$10.5K | |
| 3 | +$9.63K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.55K |
Top Sellers
| 1 | -$56K | |
| 2 | -$54.8K | |
| 3 | -$2.25K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.23K |
| 5 |
JP Morgan Chase
New York
|
-$1K |